News
Allergan said Wednesday it plans to cut more than 1,000 jobs as it braces for one of its bestselling drugs to face generic competition. Chief Executive Brent Saunders said in November that the ...
A huge part of Allergan's patent-cliff immunity against other big pharmaceuticals is its blockbuster Botox, which has helped the company evade the patent problems facing others in the industry.
The supplemental premarket approval application is supported by Phase III data, which showed significant improvements in neck ...
AbbVie announced it will buy Allergan for $63 billion, combining the companies behind Humira and Botox and creating yet another pharmaceutical behemoth. Allergan, with 2018 revenue of $15.8 ...
Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...
U.S. pharmaceutical giant Pfizer (PFE) and Irish rival Allergan (AGN) Monday announced a record-breaking $160-billion merger, the largest in health-care industry history and the biggest yet ...
Allergan agreed to acquire Tobira Therapeutics, a biopharmaceutical company that develops therapies for liver diseases, in a deal worth as much as $1.7 billion, or 19 times Tobira’s previous ...
Lab workers examine samples at an Allergan research site in France. A U.S. judge has cast doubt on the company’s scheme to protect its drug patents by trading them to a New York Indian tribe.
Irvine: AbbVie's Allergan Aesthetics has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental premarket approval (sPMA) application for SKINVIVE ...
Actavis is nearing a deal to acquire Allergan in a tie-up that would likely be the year’s largest and could help shield the Botox maker from hostile suitor Valeant.
Baltimore's outside counsel in its $45 million settlement with drugmaker Allergan will receive roughly $20 million, while the rest goes to opioid-related programs. Skip to content.
Incyte Corporation (NASDAQ:INCY) is one of the top 10 S&P 500 winners of the day that Jim Cramer highlighted. Cramer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results